MET’s interaction with its ligand, hepatocyte growth factor/scatter factor (HGF/SF), is particularly critical in promoting the epithelial to mesenchymal transition (EMT), which enhances tumor cell proliferation, motility, and anchorage-independent growth [1]. Here, MET is linked to neoplasm.